Ownership history in CITADEL ADVISORS LLC · 44 quarters on record
This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in ESSA PHARMA INC (EPIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 144,449 | +122,349 | +553.6% | 0.00% | $28K | — |
| 2025 Q3 | ADDED | 22,100 | +7,200 | +48.3% | 0.00% | $4K | — |
| 2025 Q3 | REDUCED | 14,900 | -39,139 | -72.4% | 0.00% | $3K | — |
| 2025 Q2 | REDUCED | 54,039 | -8,961 | -14.2% | 0.00% | $92K | — |
| 2025 Q2 | ADDED | 63,000 | +34,400 | +120.3% | 0.00% | $107K | — |
| 2025 Q2 | REDUCED | 28,600 | -53,523 | -65.2% | 0.00% | $49K | — |
| 2025 Q1 | ADDED | 82,123 | +81,923 | +40961.5% | 0.00% | $130K | — |
| 2025 Q1 | REDUCED | 200 | -42,100 | -99.5% | 0.00% | $316 | — |
| 2025 Q1 | REDUCED | 42,300 | -116,741 | -73.4% | 0.00% | $67K | — |
| 2024 Q4 | ADDED | 159,041 | +143,941 | +953.3% | 0.00% | $285K | — |
As of 2025 Q3 — sorted by position size